NSE / BSEConsumer Discretionary
βΉ3141.70-18.30-0.58%
P/E36.2Mkt CapβΉ14.15 K CrEV/EBITDA20.6
Akzo Nobel India Limited
P/E36.2Mkt CapβΉ14.15 K CrEV/EBITDA20.6
Company Profile
Description not available.
Valuation
Market Cap
βΉ0.00
β
Current Price
βΉ0
βas of 15 Sept 2026
P/E Ratio
0.0x
β
P/B Ratio
0.0x
β
EV / EBITDA
0.0x
β
EV / Sales
0.0x
β
52W High
βΉ0
β
52W Low
βΉ0
β
Shares Out
0.00 Cr
β
Profitability
Operating Margin
0.0%
β
Net Profit Margin
0.0%
β
EBITDA Margin
0.0%
β
Returns
ROE
0.0%
β
ROCE
0.0%
β
ROIC %
β
β
ROA
0.0%
β
Dividend Payout
0.0%
β
Solvency
Current Ratio
0.0x
β
Debt / Equity
0.0x
β
Debt / Assets
0.0x
β
CFO / Net Profit
0.0x
β
Interest Coverage
0.0x
β
AI Summary
Indian StockStrengths1
- Healthy return on equity of 32.1%
Concerns1
- Negative free cash flow (βΉ26 Cr)
Rule-based from financial data. Not advice.
Price HistoryβΌ 7.21% over 1Y
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
RevenueβΉ4.09 K Crβ² 3.3%
EBITDA Growthβ
Net ProfitβΉ429.00 Crβ² 0.5%
Cash from Ops (CFO)β
Free Cash Flow (FCF)ββΌ 36.6%
Revenue CAGR 5Y8.3%
EBITDA CAGR 5Y10.2%
Net Profit CAGR 5Y12.5%
NP Growth 1Y0.5%
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ4.09 K Cr | β | βΉ429.00 Cr | β | β | 32.3% | 3.3% | 0.5% |
| Mar 2024 | βΉ3.96 K Cr | β | βΉ427.00 Cr | β | β | 32.1% | 4.2% | 27.5% |
| Mar 2023 | βΉ3.80 K Cr | β | βΉ335.00 Cr | β | β | 25.5% | 20.7% | 15.5% |
| Mar 2022 | βΉ3.15 K Cr | β | βΉ290.00 Cr | β | β | 23.0% | 30.1% | 39.4% |
| Mar 2021 | βΉ2.42 K Cr | β | βΉ208.00 Cr | β | β | 16.1% | -9.1% | -12.2% |
| Mar 2020 | βΉ2.66 K Cr | β | βΉ237.00 Cr | β | β | 19.1% | -8.8% | 12.3% |
| Mar 2019 | βΉ2.92 K Cr | β | βΉ211.00 Cr | β | β | 18.6% | 7.3% | -47.4% |
| Mar 2018 | βΉ2.72 K Cr | β | βΉ401.00 Cr | β | β | 31.1% | 5.7% | 62.3% |
| Mar 2017 | βΉ2.57 K Cr | β | βΉ247.00 Cr | β | β | 24.5% | -2.6% | 15.4% |
| Mar 2016 | βΉ2.64 K Cr | β | βΉ214.00 Cr | β | β | 18.4% | 8.1% | 15.1% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Free plan Β· showing 1 year of data.Upgrade
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 3,903 |
| Total Expenses | 3,332 |
| EBIT / Operating Profit | 571 |
| OPM % | 15% |
| Other Income | 1,900 |
| Finance Costs | 11 |
| Depreciation & Amortisation | 82 |
| Profit Before Tax | 2,378 |
| Tax % | - |
| Net Profit / PAT | 1,990 |
| EPS (βΉ) | 436.94 |
| Dividend Payout % | - |
Peer Comparison
Consumer Discretionary sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Akzo Nobel India Limitedthis co. | βΉ14.15 K Cr | βΉ4.09 K Cr | 36.20 | 6.27 | 20.60 | 3.3% |
| Titan Company Limited | βΉ3.76 L Cr | βΉ54.84 K Cr | 96.60 | 21.09 | 69.49 | 16.4% |
| Eternal Limited | βΉ2.84 L Cr | βΉ8.62 K Cr | 120.00 | 7.95 | 193.91 | 30.1% |
| Avenue Supermarts Limited | βΉ2.49 L Cr | βΉ57.79 K Cr | 79.80 | 10.46 | 57.86 | 16.7% |
| Trent Ltd [Lakme Ltd] | βΉ1.39 L Cr | βΉ16.67 K Cr | 82.40 | 21.09 | 49.02 | 39.8% |
| Marico Limited | βΉ98.15 K Cr | βΉ7.58 K Cr | 52.30 | 19.38 | 63.51 | 8.3% |
| SWIGGY LIMITED | βΉ96.87 K Cr | βΉ8.80 K Cr | β | 7.26 | -63.92 | 38.0% |
| Industry Average | β | βΉ4.70 K Cr | 80.04 | 7.96 | 62.25 | 24.3% |